TIRZEPATIDE vs TISAGENLECLEUCEL: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
TIRZEPATIDE vs TISAGENLECLEUCEL: Safety Overview
| Metric | TIRZEPATIDE | TISAGENLECLEUCEL |
|---|---|---|
| Total FAERS Reports | 99,893 | 4,229 |
| Deaths Reported | 455 | 1,232 |
| Death Rate | 0.5% | 29.1% |
| Hospitalizations | 5,527 | 1,256 |
| Average Patient Age | 53.9 yrs | 39.1 yrs |
| % Female Patients | 75.6% | 38.4% |
| FDA Approval Date | Jan 20, 2026 | N/A |
| Manufacturer | Eli Lilly and Company | Novartis Pharmaceuticals Corporation |
| Route | N/A | INTRAVENOUS |
| Marketing Status | Prescription | N/A |